A single dose of HPV vaccine is sufficient to prevent cervical cancer.

A single dose of HPV vaccine is sufficient to prevent cervical cancer.

Meetings held on April 4-7 to evaluate research on vaccine efficacy WHOThe Experts Advisory Group on Immunity (SAGE), in its assessment published after the meetings, HPV vaccineshared the latest data on the effectiveness of

The group’s assessment concluded that “a single dose of HPV vaccine provides sufficient robust protection against cervical cancer.”

It was emphasized that the result of the research on the HPV vaccine is “game-changer” and that the use of a single dose worldwide can provide more people with access to the vaccine in middle and low-income countries and prevent more cancer cases.

In the previous guidelines of SAGE, 2 doses of HPV vaccine were recommended to children, young and adult women.

300,000 female cervical cancer victims each year

According to WHO data, more than 300,000 women die each year due to cervical cancer.

While 9 out of 10 cervical cancer cases occur in low- and middle-income countries, these cases are often caused by a lack of access to the HPV vaccine.

WHO, within the scope of the “Global Strategy to Accelerate the Elimination of Cervical Cancer” program, aims to have 90 percent of women in the world receive HPV vaccine and 70 percent of them will be screened for cancer.

If these measures are taken, it is predicted that cervical cancer deaths will decrease by 40 percent by 2050.

On the Anadolu Agency website, news presented to subscribers via the AA News Flow System (HAS) is published in summary. Please contact for subscription.

similar posts

Leave a Reply